Acepodia

Series-B
acepodia.com Biotech & Healthcare Alameda, United States 51–100 employees
Total Funding $256M
Latest Round $100M Series-B
Last Announced Jun 7, 2023
Investors 11 Backers
Decision Makers 5 Available

About Acepodia

Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Alameda, United States
Team Size 51–100 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website acepodia.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @AcepodiaInc (161 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $100,000,000 · Series-B

    Backed by Digital Mobile Venture

  2. Capital Raise

    Raised $109,000,000 · Series-B

    Backed by Digital Mobile Venture

  3. Capital Raise

    Raised $47,000,000 · Series-B

    Backed by Ridgeback Capital

Investors & Backers

11
Digital Mobile Venture
Lead
Ridgeback Capital
Lead
8VC
CDIB Capital
DEFTA Partners
Integral Group
Jerry Yang
Maxpro Ventures
Samuel Chen
Terry Gou
TopTaiwan

Funding History

3 Rounds
Series-B equity · Jun 7, 2023

Round backers: Digital Mobile Venture

Series-B equity · Dec 2, 2021

Round backers: Digital Mobile Venture

$109,000,000 globenewswire.com
Series-B equity · Mar 16, 2021

Round backers: Ridgeback Capital

$47,000,000 bioworld.com

Founders & Leadership

3

Jennifer Wang,

CTO

Work email & phone locked Unlock →

Patrick Y. Yang

Founder

Work email & phone locked Unlock →

Sonny Hsiao

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts